PHASE I DOSE‐ESCALATION STUDY OF VENETOCLAX PLUS BEAM FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR CHEMORESISTANT, RELAPSED/REFRACTORY, OR HIGH‐RISK NON‐HODGKIN'S LYMPHOMA (NHL); PRELIMINARY RESULTS.

Autor:	Maakaron, J., Zhao, Q., Puto, M., Von Derau, R., Robinson, J., Brammer, J., Penza, S., Baiocchi, R., Christian, B., Maddocks, K., Saad, A., Wall, S., Benson, D., Efebera, Y., Rosko, A., Ayyappan, S., Grieselhuber, N., Vasu, S., Larkin, K., Epperla, N.
Předmět:	LYMPHOMAS STEM cell transplantation TUMOR lysis syndrome CHRONIC lymphocytic leukemia
Zdroj:	Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p528-529, 2p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text